Hope for Depression Blog

Guest Bloggers

  • Louisa Benton

    Executive Director

  • Steven P. Roose, M.D

    Professor of Clinical Psychiatry

  • Huda Akil, Ph.D

    DTF Chair

Neuroscience Delivers New Drug for Postpartum Depression, Friday 22 March 2019

F.D.A. Approves Drug for Postpartum Depression

One in nine women in the United States experience symptoms of postpartum depression, a terrifying illness that is often difficult to treat.

That’s why we’re excited by news that the FDA has approved Brexanolone, a drug over 40 years in the making that is the first ever to specifically target the condition.  (New York Times: F.D.A. Approves First Drug for Postpartum Depression)

The approval of Brexanolone is a cause for celebration for the entire field of neuroscience.

“It is one of the first drugs that fulfills the promise of basic neuroscience to provide truly novel and effective treatments for psychiatric disorders,” said National Institute of Mental Health Director Dr. Joshua Gordon, who was also a founding member of HDRF’s Depression Task Force before he was tapped by the federal government.

Click here to read the full article…

Audrey Gruss Honored as Woman of Distinction by Palm Beach Atlantic University, Tuesday 5 March 2019

Bonnie McElveen-Hunter (2018 Women of Distinction honoree) , Audrey Gruss,  Laurie Silvers, Candy Carson (2018 Women of Distinction honoree)

We are proud to announce that Hope for Depression Research (HDRF) founder and Chair Audrey Gruss recently was honored at the 2019 Women of Distinction luncheon by Palm Beach Atlantic (PBA) University in Florida.

The luncheon, held February 19 at the Breakers Hotel in Palm Beach, is an annual event in its 28th year that honors women who have made significant contributions to the community. Proceeds fund scholarships for young women at the University.

In her remarks, Gruss told the 450 people gathered for the luncheon about her resolve to launch the Hope for Depression Research Foundation in 2006.   It was the pain of watching her own mother struggle with severe depression for over 30 years, Gruss explained, that opened her eyes to her life’s greater purpose.

Click here to read the full article…

Novel Depression Treatment in the News, Friday 15 February 2019

In a milestone for the field, the new drug Esketamine is expected to be approved by the FDA

Many of you have seen in the headlines that a new antidepressant is expected to soon be approved by the Food and Drug Administration.

The New York Times reported yesterday that an advisory panel at the agency has voted in favor of recommending approval of the new drug, the nasal spray Esketamine, to treat severely depressed patients.  Developed by Johnson & Johnson, Esketamine is a form of ketamine,  an anesthetic for humans and also a powerful sedative for horses.  (Click here for the story.)

If approved, Esketamine would provide patients that have failed more than two depression treatments with a rapidly-acting drug that is effective in a matter of days.   Currently available antidepressants can take several weeks before they are effective.  Its rapid action makes ketamine a valuable treatment for suicidal depression.

Click here to read the full article…

HDRF Brings Mental Health Awareness to Schools, Thursday 14 February 2019

Seated Left to Right: Jeff Lima, Kelly Lennon-Martucci, Louisa Benton, and Hope Kronman
Standing: Daniel Lampert and Aidan Golub, Student Organizers

Hope for Depression Research Foundation was proud to conduct an expert panel on “Bullying and Mental Health” at the Open Minds summit held January 10 at the Solomon Schechter High School in Westchester, NY.

Our panel consisted of mental health activists and scientists who spoke to an auditorium of 100 students and their teachers about how bullying can get under our skin to create mental and physical health problems later in life.

Click here to read the full article…

Growing Old Happy, Wednesday 6 February 2019

February! As we move into the second month of the year, we are thinking about how quickly time can pass.   For many, the start of a new year is a time to reflect on time itself and, of course, our own years of life.

Though growing old is a natural process that we all know to expect, it is important to be aware of common mental health risks that can come with advancing age.  For example, experts warn that men ages 65 and older show the highest incidence of suicide than any other age group.*

Here at HDRF we are invested in making sure everybody has the information and resources to maximize mental health, and we would like to share some tips and research with you.

One of the largest factors affecting mental health in older adults is the existence of a strong support system and community.

Click here to read the full article…